Status:
UNKNOWN
The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Coronary Artery Bypass Graft Redo
General Anesthetic Drug Adverse Reaction
Eligibility:
All Genders
40-60 years
Phase:
PHASE4
Brief Summary
This study is to assess the effect of desflurane on myocardial function in patents who underwent coronary artery bypass grafting.
Detailed Description
Desflurane, one of the third-generation inhaled anesthetics, is introduced in clinical practice in 1990s. Decades of clinical use has provided evidence for desflurane's safe and efficacious use as a gene...
Eligibility Criteria
Inclusion
- 1\. Diagnosed with CAD 2. ASAⅡ～Ⅲ
- \-
Exclusion
- Left ventricular ejection fraction \<40%
- Left ventricular aneurysm
- Acute myocardial infarction in latest two weeks, atrial fibrillation
- Associated vascular diseases, severe systemic diseases involving the renal and hepatic systems
- Respiratory disease( forced vital capacity less than 50% of predicted values )
- Preoperative left bundle branch block -
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02213718
Start Date
July 1 2014
End Date
June 1 2017
Last Update
August 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Anesthesiolgy, Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030